These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 14715276)

  • 1. Heparin affin regulatory peptide in milk: its involvement in mammary gland homeostasis.
    Bernard-Pierrot I; Delbé J; Heroult M; Rosty C; Soulié P; Barritault D; Milhiet PE; Courty J
    Biochem Biophys Res Commun; 2004 Jan; 314(1):277-82. PubMed ID: 14715276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular distribution of the angiogenic factor heparin affin regulatory peptide (HARP) mRNA and protein in the human mammary gland.
    Ledoux D; Caruelle D; Sabourin JC; Liu J; Crepin M; Barritault D; Courty J
    J Histochem Cytochem; 1997 Sep; 45(9):1239-45. PubMed ID: 9283611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of heparin affin regulatory peptide signaling in human endothelial cells.
    Polykratis A; Katsoris P; Courty J; Papadimitriou E
    J Biol Chem; 2005 Jun; 280(23):22454-61. PubMed ID: 15797857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.
    Héroult M; Bernard-Pierrot I; Delbé J; Hamma-Kourbali Y; Katsoris P; Barritault D; Papadimitriou E; Plouet J; Courty J
    Oncogene; 2004 Mar; 23(9):1745-53. PubMed ID: 15001987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of heparin affin regulatory peptide domains with potential role on angiogenesis.
    Polykratis A; Delbé J; Courty J; Papadimitriou E; Katsoris P
    Int J Biochem Cell Biol; 2004 Oct; 36(10):1954-66. PubMed ID: 15203110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synthetic peptide P111-136 derived from the C-terminal domain of heparin affin regulatory peptide inhibits tumour growth of prostate cancer PC-3 cells.
    Hamma-Kourbali Y; Bermek O; Bernard-Pierrot I; Karaky R; Martel-Renoir D; Frechault S; Courty J; Delbé J
    BMC Cancer; 2011 May; 11():212. PubMed ID: 21624116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of heparin affin regulatory peptide in human prostate cancer.
    Vacherot F; Caruelle D; Chopin D; Gil-Diez S; Barritault D; Caruelle JP; Courty J
    Prostate; 1999 Feb; 38(2):126-36. PubMed ID: 9973098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of heparin on bovine epithelial lens cell proliferation induced by heparin affin regulatory peptide.
    Delbé J; Vacherot F; Laaroubi K; Barritault D; Courty J
    J Cell Physiol; 1995 Jul; 164(1):47-54. PubMed ID: 7790396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dominant negative effectors of heparin affin regulatory peptide (HARP) angiogenic and transforming activities.
    Bernard-Pierrot I; Delbé J; Rouet V; Vigny M; Kerros ME; Caruelle D; Raulais D; Barritault D; Courty J; Milhiet PE
    J Biol Chem; 2002 Aug; 277(35):32071-7. PubMed ID: 12070152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lysine-rich C-terminal tail of heparin affin regulatory peptide is required for mitogenic and tumor formation activities.
    Bernard-Pierrot I; Delbe J; Caruelle D; Barritault D; Courty J; Milhiet PE
    J Biol Chem; 2001 Apr; 276(15):12228-34. PubMed ID: 11150308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosaminoglycans promote HARP/PTN dimerization.
    Bernard-Pierrot I; Héroult M; Lemaître G; Barritault D; Courty J; Milhiet PE
    Biochem Biophys Res Commun; 1999 Dec; 266(2):437-42. PubMed ID: 10600521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial cell proliferation induced by HARP: implication of N or C terminal peptides.
    Papadimitriou E; Heroult M; Courty J; Polykratis A; Stergiou C; Katsoris P
    Biochem Biophys Res Commun; 2000 Jul; 274(1):242-8. PubMed ID: 10903925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin affin regulatory peptide modulates the endogenous anticoagulant activity of heparin and heparan sulphate mimetics.
    Mejdoubi-Charef N; Courty J; Sineriz F; Papy-Garcia D; Charef S
    Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):296-302. PubMed ID: 22672269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleiotrophin (PTN) expression and function and in the mouse mammary gland and mammary epithelial cells.
    Rosenfield SM; Bowden ET; Cohen-Missner S; Gibby KA; Ory V; Henke RT; Riegel AT; Wellstein A
    PLoS One; 2012; 7(10):e47876. PubMed ID: 23077670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The angiogenic factor heparin affin regulatory peptide (HARP) induces proliferation of human peripheral blood mononuclear cells.
    Achour A; Laaroubi D; Caruelle D; Barritault D; Courty J
    Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL73-7. PubMed ID: 11936877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin affin regulatory peptide is a key player in prostate cancer cell growth and angiogenicity.
    Hatziapostolou M; Delbe J; Katsoris P; Polytarchou C; Courty J; Papadimitriou E
    Prostate; 2005 Oct; 65(2):151-8. PubMed ID: 15924335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and mitogenic properties of the heparin-binding growth factor HARP.
    Laaroubi K; Vacherot F; Delbé J; Caruelle D; Barritault D; Courty J
    Prog Growth Factor Res; 1995; 6(1):25-34. PubMed ID: 8714367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin affin regulatory peptide: a new target for tumour therapy?
    Papadimitriou E; Polykratis A; Hatziapostolou M; Parthymou A; Polytarchou C; Mikelis C
    Curr Cancer Drug Targets; 2004 Sep; 4(6):471-82. PubMed ID: 15379633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitogenic and in vitro angiogenic activity of human recombinant heparin affin regulatory peptide.
    Laaroubi K; Delbé J; Vacherot F; Desgranges P; Tardieu M; Jaye M; Barritault D; Courty J
    Growth Factors; 1994; 10(2):89-98. PubMed ID: 7520717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HARP induces angiogenesis in vivo and in vitro: implication of N or C terminal peptides.
    Papadimitriou E; Polykratis A; Courty J; Koolwijk P; Heroult M; Katsoris P
    Biochem Biophys Res Commun; 2001 Mar; 282(1):306-13. PubMed ID: 11264008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.